8 citations
,
May 2016 in “Indian Journal of Pharmacology”
This case report describes an atypical postfinasteride syndrome in a patient treated with both dutasteride and finasteride for androgenic alopecia, highlighting its multisystem involvement and irreversible nature.
20 citations
,
August 2008 in “Journal of Medical Case Reports”
This case report describes a probable hypersensitivity reaction to a single intravenous dose of ondansetron, highlighting the need for cautious use, especially in outpatient settings.
1 citations
,
September 2017 in “Asian Journal of Pharmaceutical and Clinical Research”
This case report documents warfarin-induced alopecia in a 39-year-old male in Southern India, adding to the limited case reports on this potential side effect.
January 2026 in “British Journal of Clinical Pharmacology”
In this study, reports from individuals using Serenoa repens indicated a possible post-Serenoa syndrome characterized by persistent sexual and neuropsychiatric symptoms, with causality assessed as 'probable' in 54% of cases, highlighting an underrecognized safety concern that warrants further investigation.